AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 37 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 2.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,292 | +325.0% | 783 | +193.3% | 0.00% | – |
| Q1 2023 | $304 | -98.6% | 267 | -98.9% | 0.00% | – |
| Q4 2022 | $21,886 | -37.5% | 24,261 | -19.0% | 0.00% | – |
| Q3 2022 | $35,000 | +25.0% | 29,942 | -32.4% | 0.00% | – |
| Q2 2022 | $28,000 | -79.4% | 44,299 | -15.2% | 0.00% | – |
| Q1 2022 | $136,000 | -54.2% | 52,252 | -31.6% | 0.00% | – |
| Q4 2021 | $297,000 | +330.4% | 76,393 | +382.6% | 0.00% | – |
| Q3 2021 | $69,000 | +23.2% | 15,831 | +13.1% | 0.00% | – |
| Q2 2021 | $56,000 | -58.5% | 13,992 | -46.2% | 0.00% | – |
| Q1 2021 | $135,000 | +13400.0% | 25,989 | +20363.8% | 0.00% | – |
| Q3 2020 | $1,000 | -97.1% | 127 | -98.2% | 0.00% | – |
| Q2 2020 | $34,000 | – | 7,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $79,487,000 | 78.22% |
| GSA CAPITAL PARTNERS LLP | 11,400 | $79,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 97,000 | $670,000 | 0.01% |
| Trexquant Investment LP | 12,912 | $89,000 | 0.01% |
| Spark Investment Management LLC | 11,600 | $80,000 | 0.00% |
| Baker Brothers Advisors | 99,600 | $688,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 23,735 | $164,000 | 0.00% |
| TIVERTON ASSET MANAGEMENT LLC | 10,742 | $74,000 | 0.00% |
| MACKAY SHIELDS LLC | 16,600 | $115,000 | 0.00% |
| ALLIANCEBERNSTEIN L.P. | 316,464 | $2,187,000 | 0.00% |